Statistics

Total Visits

Views
Pharmacoeconomic evaluation of tocilizumab monotherapy vs. Adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis44

Select a period of time:

Number of views in the range

Views
Pharmacoeconomic evaluation of tocilizumab monotherapy vs. Adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis7

Views

Views
May 20250
June 20250
July 20256
August 20250
September 20250
October 20251
November 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil4
United States2
Angola1
 

Top cities views

Views
Catanduva1
Charlotte1
Londrina1
Louveira1
Luanda1
McKinney1
Volta Redonda1